MECHANISMS OF DEFICIENT TYPE I PROTEIN KINASE A ACTIVITY IN LUPUS T LYMPHOCYTES

REFERENCES

• G.M., Kammer, G.C., Tsokos. Lupus: Molecular and Cellular Pathogenesis. Totowa, NJ, Humana Press. 1999
   Google Scholar
• G.M., Kammer, A., Perl, B.C., Richardson, G.C., Tsokos. Abnormal T cell signal transduction in systemic lupus erythematosus. Arthritis Rheum.. 46: 1139–1154, 2002
   PubMed Web of Science ®Google Scholar
• G.M., Kammer. Impaired T cell capping and receptor regeneration in active systemic lupus erythematosus: evidence for a disorder intrinsic to the T lymphocyte. J. Clin. Invest.. 72: 1686–1697, 1983
   PubMedGoogle Scholar
• A.K., Dayal, G.M., Kammer. The T cell enigma in lupus. Arthritis Rheum.. 39: 23–33, 1996
   PubMed Web of Science ®Google Scholar
• G.C., Tsokos, G.M., Kammer. Molecular aberrations in human systemic lupus erythematosus. Mol. Med. Today. 6: 418–424, 2000, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• J.J., O'Shea. Jaks, STATs, cytokine signal transduction, and immunoregulation: Are we there yet?. Immunity. 7: 1–11, 1997, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• M., Mellado, J.M., Rodriguez-Frade, S., Manes, C., Martinez-A. Chemokine signaling and functional responses: The role of receptor dimerization and TK pathway activation. Annu. Rev. Immunol.. 19: 397–421, 2001, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M.H., Wener. Immune complexes. G.C., Tsokos. Principles of Molecular Rheumatology. Totowa, NJ, Humana Press. 127–144, 2000
   Google Scholar
• P., Gergely, Jr., B., Niland, N., Gonchoroff, R., Pullmann, Jr., P.E., Phillips, A., Perl. Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosus. J Immunol.. 169: 1092–1101, 2002
   PubMed Web of Science ®Google Scholar
• H.K., Wong, G.M., Kammer, G., Dennis, G.C., Tsokos. Abnormal NF-κB activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression. J. Immunol.. 163: 1682–1689, 1999
   PubMed Web of Science ®Google Scholar
• R., Mandler, R.E., Birch, S., Polmar, G.M., Kammer, S.A., Rudolph. Abnormal adenosine-induced immunosuppression and cAMP metabolism in T lymphocytes of patients with systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA. 79: 7542–7546, 1982
   PubMedGoogle Scholar
• P., Hasler, L.A., Schultz, G.M., Kammer. Defective cAMP-dependent phosphorylation of intact T lymphocytes in active systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA. 87: 1978–1982, 1990, [CSA]
   PubMedGoogle Scholar
• G.M., Kammer, I.U., Khan, C.J., Malemud. Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes. J. Clin. Invest.. 94: 422–430, 1994, [CSA]
   PubMed Web of Science ®Google Scholar
• G.M., Kammer. High prevalence of T cell type I protein kinase A deficiency in systemic lupus erythematosus. Arthritis Rheum.. 42: 1458–1465, 1999, [CROSSREF]
   PubMedGoogle Scholar
• N., Mishra, I.U., Khan, G.C., Tsokos, G.M., Kammer. Association of deficient type II protein kinase A activity with aberrant nuclear translocation of the RIIβ-subunit in systemic lupus erythematosus T lymphocytes. J. Immunol.. 165: 2830–2840, 2000
   PubMedGoogle Scholar
• A.M., Edelman, D.K., Blumenthal, E.G., Krebs. Protein serine/threonine kinases. Ann. Rev. Biochem.. 56: 567–613, 1987
   PubMed Web of Science ®Google Scholar
• B.S., Skålhegg, K., Taskén. Specificity in the cAMP/PKA signaling pathway Differential expression, regulation, and subcellular localization of subunits of PKA, Front. Biosci.. 5: D678–D693, 2000
   Google Scholar
• S.H., Francis, J.D., Corbin. Cyclic nucleotide-dependent protein kinases: intracellular receptors for cAMP and cGMP action. Crit. Rev. Clin. Lab. Sci.. 36: 275–328, 1999, [CSA]
   PubMed Web of Science ®Google Scholar
• H., Kawasaki, G.M., Springett, N., Mochizuki, S., Toki, M., Nakaya, M., Matsuda, D.E., Housman, A.M., Graybiel. A family of cAMP-binding proteins that directly activate Rap1. Science. 282: 2275–2279, 1998, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• M., Colledge, J.D., Scott. AKAPs: From structure to function. Trends Cell Biol.. 9: 216–221, 1999, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• L.J.S., Huang, K., Durick, J.A., Weiner, J., Chun, S.S., Taylor. Identification of a novel protein kinase A anchoring protein that binds both type I and type II regulatory subunits. J. Biol. Chem.. 272: 8057–8064, 1997, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• A., Feliciello, M.E., Gottesman, E.V., Avvedimento. The biological functions of A-kinase anchor proteins. J. Mol. Biol.. 308: 99–114, 2001, [CROSSREF]
   PubMedGoogle Scholar
• H., Shuntoh, R.A., Steinberg. Analysis of the dominance of mutations in cAMP-binding sites of murine type I cAMP-dependent protein kinase in activation of kinase from heterozygous mutant lymphoma cells. J. Cell. Physiol.. 146: 86–93, 1991, [CROSSREF]
   PubMedGoogle Scholar
• K., Taskén, B.S., Skalhegg, R., Solberg, K.B., Andersson, S.S., Taylor, T., Lea, H.K., Blomhoff, T., Jahnsen, V., Hansson. Novel isozymes of cAMP-dependent protein kinase exist in human cells due to formation of RIα-RIβ heterodimeric complexes. J. Biol. Chem.. 268: 21276–21283, 1993
   PubMedGoogle Scholar
• M.O., Showers, R.A., Maurer. A cloned bovine cDNA encodes an alternate form of the catalytic subunit of cAMP-dependent protein kinase. J. Biol. Chem.. 261: 16288–16291, 1986
   PubMedGoogle Scholar
• P., Hasler, J.J., Moore, G.M., Kammer. Human T lymphocyte cAMP-dependent protein kinase: Subcellular distributions and activity ranges of type I and type II isozymes. FASEB J.. 6: 2735–2741, 1992
   PubMedGoogle Scholar
• R.V., Schillace, S.F., Andrews, G.A., Liberty, M.P., Davey, D.W., Carr. Identification and characterization of myeloid translocation gene 16b as a novel A-kinase anchoring protein in T lymphocytes. J. Immunol.. 168: 1590–1599, 2002
   PubMed Web of Science ®Google Scholar
• R.O., Williams. Cutting edge: A-kinase anchor proteins are involved in maintaining resting T cells in an inactive state. J. Immunol.. 168: 5392–5396, 2002
   PubMedGoogle Scholar
• B.S., Skålhegg, K., Taskén, V., Hansson, H.S., Huitfeldt, T., Jahnsen, T., Lea. Location of cAMP-dependent protein kinase type I with the TCR-CD3 complex. Science. 263: 84–87, 1994
   PubMed Web of Science ®Google Scholar
• O., Witczak, B.S., Skålhegg, G., Keryer, M., Bornens, K., Taskén, T., Jahnsen, S., Ørstavik. Cloning and characterization of a cDNA encoding an A-kinase anchoring protein located in the centrosome, AKAP450. EMBO J.. 18: 1858–1868, 1999, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• D., Diviani, L.K., Langeberg, S.J., Doxsey, J.D., Scott. Pericentrin anchors protein kinase A at the centrosome through a newly identified RII-binding domain. Curr. Biol.. 10: 417–420, 2000, [CROSSREF]
   Google Scholar
• E.A., Nigg, G., Schafer, H., Hilz, H.M., Eppenberger. Cyclic AMP-dependent protein kinase type II is associated with the Golgi complex and with centrosomes. Cell. 41: 1039–1051, 1985, [CROSSREF]
   PubMedGoogle Scholar
• H., Harada, B., Becknell, M., Wilm, M., Mann, L.J., Huang, S.S., Taylor, J.D., Scott, S.J., Korsmeyer. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol. Cell. 3: 413–422, 1999, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• N.M., Alto, J., Soderling, J.D., Scott. Rab32 is an A-kinase anchoring protein and participates in mitochondrial dynamics. J. Cell Biol.. 158: 659–668, 2002, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• G.M., Kammer, R.L., Stein. T lymphocyte immune dysfunctions in systemic lupus erythematosus. J. Lab. Clin. Med.. 115: 273–282, 1990, [CSA]
   PubMedGoogle Scholar
• D.R., Webb, I., Nowowiejski, M., Dauphinee, N., Talal. Antigen induced alterations in splenic prostaglandin and cyclic nucleotide levels in NZB mice. J. Immunol.. 118: 446–450, 1977
   PubMedGoogle Scholar
• R.R., Skelly, A.D., Steinberg, O.J., Plescia. Regulation of antigen-induced changes in cyclic nucleotide levels in NZB/WF1 mice. Cell. Immunol.. 36: 283–293, 1978, [CROSSREF]
   PubMedGoogle Scholar
• G.M., Kammer, R.E., Birch, S., Polmar. Impaired immunoregulation in systemic lupus erythematosus: Defective adenosine-induced suppressor T lymphocyte generation. J. Immunol.. 130: 1706–1712, 1983
   PubMedGoogle Scholar
• G.M., Kammer, S.A., Rudolph. Regulation of human T lymphocyte surface antigen mobility by purinergic receptors. J. Immunol.. 133: 3298–3302, 1984
   PubMedGoogle Scholar
• G.M., Kammer, C.A., Boehm, S.A., Rudolph, L.A., Schultz. Mobility of the human T lymphocyte surface molecules CD3,CD4 and CD8: regulation by a cAMP-dependent pathway. Proc Natl. Acad. Sci. USA. 85: 792–796, 1988, [CSA]
   PubMed Web of Science ®Google Scholar
• L.A., Schultz, G.M., Kammer, S.A., Rudolph. Characterization of the human T lymphocyte adenosine receptor: comparison of normal and systemic lupus erythematosus cells. FASEB J.. 2: 244–250, 1988
   PubMedGoogle Scholar
• G.M., Kammer, J.A., Smith, R., Mitchell. Capping of human T cell specific determinants: kinetics of capping and receptor re-expression and regulation by the cytoskeleton. J. Immunol.. 130: 38–44, 1983
   PubMedGoogle Scholar
• G.M., Kammer, E., Mitchell. Impaired mobility of human T lymphocyte surface molecules during inactive systemic lupus erythematosus. Relationship to a defective cAMP pathway. Arthritis Rheum.. 31: 88–98, 1988
   PubMedGoogle Scholar
• M.P., Nambiar, E.J., Enyedy, C.U., Fisher, S., Krishnan, V.G., Warke, W.R., Gilliland, R.J., Oglesby, G.C., Tsokos. Abnormal expression of various molecular forms and distribution of T cell receptor ζ chain in patients with systemic lupus erythematosus. Arthritis Rheum.. 46: 163–174, 2002, [CROSSREF]
   PubMedGoogle Scholar
• D., Laxminarayana, A., Berrada, G.M., Kammer. Early events of human T lymphocyte activation are associated with type I protein kinase A activity. J. Clin. Invest.. 92: 2207–2214, 1993
   PubMedGoogle Scholar
• I.U., Khan, R., Wallin, R.S., Gupta, G.M., Kammer. Protein kinase A-catalyzed phosphorylation of heat shock protein 60 chaperone regulates its attachment to histone 2B in the T lymphocyte plasma membrane. Proc. Natl. Acad. Sci. USA. 95: 10425–10430, 1998, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• G.M., Kammer, I.U., Khan, J.A., Kammer, I., Olorenshaw, D., Mathis. Deficient type I protein kinase A activity in systemic lupus erythematosus T lymphocytes. II. Abnormal isozyme kinetics. J. Immunol.. 157: 2690–2698, 1996
   PubMedGoogle Scholar
• D., Laxminarayana, I.U., Khan, N., Mishra, I., Olorenshaw, K., Taskén, G.M., Kammer. Diminished levels of protein kinase A RIα and RIβ transcripts and proteins in systemic lupus erythematosus T lymphocytes. J. Immunol.. 162: 5639–5648, 1999
   PubMedGoogle Scholar
• R., Solberg, K., Taskén, W., Wen, V.M., Coghlan, J.L., Meinkoth, J.D., Scott, T., Jahnsen, S.S., Taylor. β of cAMP-dependent protein kinases: Expression, holoenzyme formation and microinjection into living cells. Exp Cell Res.. 214: 595–605, 1994, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• P.S., Amieux, G.S., McKnight. The essential role of RIα in the maintenance of regulated PKA activity. Ann. NY Acad. Sci.. 968: 75–95, 2002
   PubMed Web of Science ®Google Scholar
• T., Vang, K.M., Torgersen, V., Sundvold, M., Saxena, F.O., Levy, B.S., Skålhegg, V., Hansson, T., Mustelin, K., Taskén. Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor. J. Exp. Med.. 193: 497–507, 2001, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• A., Grolleau, M.J., Kaplan, S.M., Hanash, L., Beretta, B.C., Richardson. Impaired translational response and increased protein kinase PKR expression in T cells from lupus patients. J. Clin. Invest.. 106: 1561–1568, 2000, [CSA]
   PubMedGoogle Scholar
• K.M., Sakamoto. Ubiquitin-dependent proteolysis: Its role in human diseases and design of therapeutic strategies. Mol. Gen. Metab.. 77: 44–56, 2002, [CSA]
   PubMed Web of Science ®Google Scholar
• A.N., Hegde, A.L., Goldberg, J.H., Schwartz. Regulatory subunits of cAMP- dependent protein kinases are degraded after conjugation to ubiquitin: A molecular mechanisms underlying long-term synaptic plasticity. Proc. Natl. Acad. Sci. USA. 90: 7436–7440, 1993, [CSA]
   PubMed Web of Science ®Google Scholar
• I.U., Khan, D., Laxminarayana, G.M., Kammer. Protein kinase A RIβ-subunit deficiency in lupus T lymphocytes: Bypassing a block in RIβ translation reconstitutes protein kinase A activity and augments IL-2 production. J. Immunol.. 166: 7600–7605, 2001
   PubMed Web of Science ®Google Scholar
• D., Laxminarayana, G.M., Kammer. mRNA mutations of type I protein kinase A regulatory subunit α in T lymphocytes of a subject with systemic lupus erythematosus. Int. Immunol.. 12: 1521–1529, 2000, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• R., Benne, J., Van den Burg, J.P., Brakenhoff, P., Sloof, J.H., Van Boom, M.C., Tromp. Major transcript of the frameshifted cox II gene from trypanosome mitochondria contains four nucleotides that are not encoded in the DNACell. 46: 819–826, 1986
   Google Scholar
• L., Simpson, O.H., Thiemann, N.J., Savill, J.D., Alfonzo, D.A., Maslov. Evolution of RNA editing in trypanosome mitochondria. Proc. Natl. Acad. Sci. USA. 97: 6986–6993, 2000, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• L.M., Powell, S.C., Wallis, R.J., Pease, Y.H., Edwards, T.J., Knott, J.D., Scott. A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in the intestine. Cell. 50: 831–840, 1987, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• B.L., Bass. RNA editing by adenosine deaminases that act on RNA. Ann. Rev. Biochem.. 71: 817–846, 2002, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• B.L., Bass, K., Nishikura, W., Keller, P.H., Seeburg, R.B., Emeson, M.A., O'Connell, C.E., Samuel, A.A., Herbert. A standardized nomenclature for adenosine deaminases that act on RNA. RNA. 3: 947–949, 1997
   PubMed Web of Science ®Google Scholar
• S., Maas, A., Rich. Changing genetic information through RNA editing. BioEssays. 22: 790–802, 2000, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• N.O., Davidson. The challenge of target sequence specificity in C to U RNA editing. J. Clin. Invest.. 109: 291–294, 2002, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Z., Zhang, G.G., Carmichael. The fate of dsRNA in the nucleus: a p54nrb- containing complex mediates the nuclear retention of promiscuously A-to-I edited RNAs. Cell. 106: 465–475, 2001, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• S.M., Rueter, T.W., Dawson, R.B., Emeson. Regulation of alternative splicing by RNA editing. Nature. 399: 75–80, 1999, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• P.S., Gulko, R.J., Winchester. erythematosus. G.M., Kammer, G.C., Tsokos. Lupus Molecular and Cellular Pathogenesis. Totowa, NJ, Humana Press. 101–123, 1999
   Google Scholar
• D., Laxminarayana, I.U., Khan, G.M., Kammer. Transcript mutations of the α regulatory subunit of protein kinase a and up-regulation of the RNA-editing gene transcript in lupus T lymphocytes. Lancet. 360: 842–849, 2002, [CROSSREF]
   PubMedGoogle Scholar
• F.W., van Leeuwen, D.P., de Kleijn, H.H., van den Hurk, A., Neubauer, M.A., Sonnemans, J.A., Sluijs, S., Koycu, R.D.J., Ramdjielal, A., Salehi, G.J.M., Martens, F.G., Grosveld, J., Peter, H., Burbach, E.M., Hol. Frameshift mutants of β amyloid precursor protein and ubiquitin-b in Alzheimer's and Down patients. Science. 279: 242–247, 1999
   Google Scholar
• F.W., van Leeuwen, J.P., Burbach, E.M., Hol. Mutations in RNA: A first example of molecular misreadings in Alzheimer's disease. Trends Neurosci.. 21: 331–335, 1999, [CSA]
   Google Scholar
• J.J., Hooks, H.M., Moutsopoulos, S.A., Geis, N.I., Stahl, J.L., Decker, A.L., Notkins. Immune interferon in the circulation of patients with autoimmune disease. New Engl. J. Med.. 301: 5–8, 1979
   PubMed Web of Science ®Google Scholar
• L.E., Ronnblom, G.V., Alm. An etiopathogenic role for the type I IFN system in SLE. Trends Immunol.. 22: 427–431, 2001, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• G.M., Kammer. Deficient protein kinase A in systemic lupus erythematosus A disorder of T lymphocyte signal transduction. Ann. N Y Acad. Sci.. 968: 96–105, 2002, [CSA]
   PubMedGoogle Scholar
• E.J., Enyedy, M.P., Nambiar, S.-N.C., Liossis, G., Dennis, G.M., Kammer, G.C., Tsokos. Fcε receptor type Ig chain replaces the deficient T cell receptor ζ chain in T cells of patients with systemic lupus erythematosus. Arthritis Rheum.. 44: 1114–1121, 2001, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• V., Brundula, L.J., Rivas, A.M., Blasini, M., París, S., Salazar, I.L., Stekman, M.A., Rodríguez. Diminished levels of T cell receptor ζ chains in peripheral blood T lymphocytes from patients with systemic lupus erythematosus. Arthritis Rheum.. 42: 1908–1916, 1999, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• C., Deng, M.J., Kaplan, J., Yang, D., Ray, Z., Zhang, W.J., McCune, S.M., Hanash, B.C., Richardson. Decreased ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum.. 44: 397–407, 2001, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• N., Mishra, D.R., Brown, I.M., Olorenshaw, G.M., Kammer. Trichostatin A reverses skewed expression of CD154, interleukin-10 and interferon-γ gene and protein expression in lupus T cells. Proc Natl. Acad. Sci. USA. 98: 2628–2633, 2001, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• A.J., Bannister, T., Kouzarides. The CBP co-activator is a histone acetyltransferase. Nature. 384: 641–643, 1996, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• L.A., Pile, E.M., Schlag, D.A., Wasserman. The SIN3/RPD3 deacetylase complex is essential for G(2) phase cell cycle progression and regulation of SMRTER corepressor levels. Mol. Cell. Biol.. 22: 4965–4976, 2002, [CROSSREF]
   PubMedGoogle Scholar
• E.E., Solomou, Y.-T., Juang, M.F., Gourley, G.M., Kammer, G.C., Tsokos. Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus. J. Immunol.. 1664216–42222001
   Google Scholar
• M., Zubiaur, M., Guirado, C., Terhorst, F., Malavasi, J., Sancho. The CD3-γ, δ, ε transducing module mediates CD38-induced protein-tyrosine kinase and mitogen-activated protein kinase activation in Jurkat T cells. J. Biol. Chem.. 274: 20633–20642, 1999, [CROSSREF]
   PubMedGoogle Scholar
• I.U., Khan, G.C., Tsokos, G.M., Kammer. Abnormal B cell signal transduction in systemic lupus erythematosus. D., Nemazee. Curr. Dir. Autoimmun. B Cell Biol. in Autoimmun.. BaselSwitzerland, S. Karger AG. 89–104, 2003
   Google Scholar
• T., Takeuchi, M., Pang, K., Amano, J., Koide, T., Abe. Reduced protein tyrosine phosphatase (PTPase) activity of CD45 on peripheral blood lymphocytes in patients with systemic lupus erythematosus. Clin. Exp. Immunol.. 109: 20–26, 1997, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• V., Rider, S.R., Jones, M., Evans, N.I., Abdou. Molecular mechanisms involved in the estrogen-dependent regulation of calcineurin in systemic lupus erythematosus T cells. Clin. Immunol.. 95: 124–134, 2000, [CROSSREF]
   PubMedGoogle Scholar
• R., Majeti, Z., Xu, T.G., Parslow, J.L., Olson, D.I., Daikh, N., Killeen, A., Weiss. An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell. 103: 1059–1070, 2000, [CROSSREF]
   PubMed Web of Science ®Google Scholar